137 related articles for article (PubMed ID: 8696946)
1. Gemfibrozil stimulates apolipoprotein A-I synthesis and secretion by stabilization of mRNA transcripts in human hepatoblastoma cell line (Hep G2).
Jin FY; Kamanna VS; Chuang MY; Morgan K; Kashyap ML
Arterioscler Thromb Vasc Biol; 1996 Aug; 16(8):1052-62. PubMed ID: 8696946
[TBL] [Abstract][Full Text] [Related]
2. Estradiol stimulates apolipoprotein A-I- but not A-II-containing particle synthesis and secretion by stimulating mRNA transcription rate in Hep G2 cells.
Jin FY; Kamanna VS; Kashyap ML
Arterioscler Thromb Vasc Biol; 1998 Jun; 18(6):999-1006. PubMed ID: 9633943
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of low density lipoprotein receptor by gemfibrozil, a hypolipidemic agent, in human hepatoma cells through stabilization of mRNA transcripts.
Goto D; Okimoto T; Ono M; Shimotsu H; Abe K; Tsujita Y; Kuwano M
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2707-12. PubMed ID: 9409246
[TBL] [Abstract][Full Text] [Related]
4. Niacin, but not gemfibrozil, selectively increases LP-AI, a cardioprotective subfraction of HDL, in patients with low HDL cholesterol.
Sakai T; Kamanna VS; Kashyap ML
Arterioscler Thromb Vasc Biol; 2001 Nov; 21(11):1783-9. PubMed ID: 11701466
[TBL] [Abstract][Full Text] [Related]
5. Niacin decreases removal of high-density lipoprotein apolipoprotein A-I but not cholesterol ester by Hep G2 cells. Implication for reverse cholesterol transport.
Jin FY; Kamanna VS; Kashyap ML
Arterioscler Thromb Vasc Biol; 1997 Oct; 17(10):2020-8. PubMed ID: 9351367
[TBL] [Abstract][Full Text] [Related]
6. Secretion of prebeta HDL increases with the suppression of cholesteryl ester transfer protein in Hep G2 cells.
Sawada S; Sugano M; Makino N; Okamoto H; Tsuchida K
Atherosclerosis; 1999 Oct; 146(2):291-8. PubMed ID: 10532685
[TBL] [Abstract][Full Text] [Related]
7. Pioglitazone stimulates apolipoprotein A-I production without affecting HDL removal in HepG2 cells: involvement of PPAR-alpha.
Qin S; Liu T; Kamanna VS; Kashyap ML
Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2428-34. PubMed ID: 17872455
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of gemfibrozil and fenofibrate on reverse cholesterol transport from macrophages to feces in vivo.
Rotllan N; Llaverías G; Julve J; Jauhiainen M; Calpe-Berdiel L; Hernández C; Simó R; Blanco-Vaca F; Escolà-Gil JC
Biochim Biophys Acta; 2011 Feb; 1811(2):104-10. PubMed ID: 21126601
[TBL] [Abstract][Full Text] [Related]
9. Human S mu binding protein-2 binds to the drug response element and transactivates the human apoA-I promoter: role of gemfibrozil.
Mohan WS; Chen ZQ; Zhang X; Khalili K; Honjo T; Deeley RG; Tam SP
J Lipid Res; 1998 Feb; 39(2):255-67. PubMed ID: 9507986
[TBL] [Abstract][Full Text] [Related]
10. Rosuvastatin selectively stimulates apolipoprotein A-I but not apolipoprotein A-II synthesis in Hep G2 cells.
Qin S; Koga T; Ganji SH; Kamanna VS; Kashyap ML
Metabolism; 2008 Jul; 57(7):973-9. PubMed ID: 18555840
[TBL] [Abstract][Full Text] [Related]
11. Protein-DNA interactions at a drug-responsive element of the human apolipoprotein A-I gene.
Zhang X; Chen ZQ; Wang Z; Mohan W; Tam SP
J Biol Chem; 1996 Oct; 271(43):27152-60. PubMed ID: 8900208
[TBL] [Abstract][Full Text] [Related]
12. Effect of low density lipoproteins, high density lipoproteins, and cholesterol on apolipoprotein A-I mRNA in Hep G2 cells.
Monge JC; Hoeg JM; Law SW; Brewer HB
FEBS Lett; 1989 Jan; 243(2):213-7. PubMed ID: 2492952
[TBL] [Abstract][Full Text] [Related]
13. The effects of short-chain fatty acids on the transcription and secretion of apolipoprotein A-I in human hepatocytes in vitro.
Tayyeb JZ; Popeijus HE; Mensink RP; Konings MCJM; Mulders KHR; Plat J
J Cell Biochem; 2019 Oct; 120(10):17219-17227. PubMed ID: 31106471
[TBL] [Abstract][Full Text] [Related]
14. Dexamethasone increases apolipoprotein A-I concentrations in medium and apolipoprotein A-I mRNA abundance from Hep G2 cells.
Varma VK; Smith TK; Sorci-Thomas M; Ettinger WH
Metabolism; 1992 Oct; 41(10):1075-80. PubMed ID: 1328818
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of action of gemfibrozil on lipoprotein metabolism.
Saku K; Gartside PS; Hynd BA; Kashyap ML
J Clin Invest; 1985 May; 75(5):1702-12. PubMed ID: 3923042
[TBL] [Abstract][Full Text] [Related]
16. A novel compound 4010B-30 upregulates apolipoprotein A-I gene expression through activation of PPARγ in HepG2 cells.
Du Y; Wang L; Si S; Yang Y; Hong B
Atherosclerosis; 2015 Apr; 239(2):589-98. PubMed ID: 25734982
[TBL] [Abstract][Full Text] [Related]
17. Increased high density lipoprotein (HDL), defective hepatic catabolism of ApoA-I and ApoA-II, and decreased ApoA-I mRNA in ob/ob mice. Possible role of leptin in stimulation of HDL turnover.
Silver DL; Jiang XC; Tall AR
J Biol Chem; 1999 Feb; 274(7):4140-6. PubMed ID: 9933608
[TBL] [Abstract][Full Text] [Related]
18. Cell culture conditions determine apolipoprotein CIII secretion and regulation by fibrates in human hepatoma HepG2 cells.
Clavey V; Copin C; Mariotte MC; Baugé E; Chinetti G; Fruchart J; Fruchart JC; Dallongeville J; Staels B
Cell Physiol Biochem; 1999; 9(3):139-49. PubMed ID: 10494028
[TBL] [Abstract][Full Text] [Related]
19. Effects of niacin and chromium on the expression of ATP-binding cassette transporter A1 and apolipoprotein A-1 genes in HepG2 cells.
Siripurkpong P; Na-Bangchang K
J Nutr Biochem; 2009 Apr; 20(4):261-8. PubMed ID: 18602814
[TBL] [Abstract][Full Text] [Related]
20. Remodeling of HDL containing apoA-I but not apoA-II (LpA-I) by lipoprotein-deficient plasma and hepatic lipase: its effect on the structure and cellular cholesterol-reducing capacity of LpA-I.
Ohta T; Ikeda Y; Hattori S; Matsuda I
Biochim Biophys Acta; 1996 Sep; 1303(2):137-44. PubMed ID: 8856043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
